IP Library Patent Application 17103298
Patent Application
App. No. 17/103,298

DIRECT COMPRESSION MOLDED OPHTHALMIC DEVICES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/103,298
Abstract

A method for making ophthalmic devices includes direct compression molding one or more ophthalmic device forming polymers in a mold to form ophthalmic devices.

Claims (23)

1 . A method for making ophthalmic devices comprising direct compression molding one or more ophthalmic device forming polymers in a mold to form an ophthalmic device.

2 . The method of claim 1 , wherein the mold comprises a posterior mold section having a molding surface shaped to provide a posterior ophthalmic device surface and an anterior mold section having a molding surface shaped to provide an anterior ophthalmic device surface.

3 . The method of claim 2 , comprising placing the one or more ophthalmic device forming polymers in the anterior mold section and capping the anterior mold section with the posterior mold section.

4 . The method of claim 3 , further comprising de-capping the anterior mold section from the posterior mold section and releasing the ophthalmic device from either the anterior mold section or the posterior mold section.

5 . The method of claim 1 , wherein the direct compression molding is a continuous direct compression molding.

6 . The method of claim 1 , wherein the one or more ophthalmic device forming polymers comprise one or more of an aliphatic hydrophilic thermoplastic polyurethane, an aromatic hydrophilic thermoplastic polyurethane, an aliphatic hydrophilic thermoplastic polyester, an aromatic hydrophilic thermoplastic polyester, and a blend of one or more of the aliphatic hydrophilic thermoplastic polyurethane, the aromatic hydrophilic thermoplastic polyurethane, the aliphatic hydrophilic thermoplastic polyester, the aromatic hydrophilic thermoplastic polyester with a hydrophobic silicone.

7 . The method of claim 6 , wherein the aliphatic hydrophilic thermoplastic polyurethane comprises a reaction product of an aliphatic organic diisocyanate, a polyether polyol and a chain extender.

8 . The method of claim 1 , wherein the one or more ophthalmic device forming polymers comprise a blend of the one or more ophthalmic device forming polymers and one or more silicone polymers.

9 . The method of claim 8 , wherein the one or more silicone polymers include polydimethylsiloxane, dimethicone or both.

10 . The method of claim 1 , wherein the one or more ophthalmic device forming polymers comprise a blend of the one or more ophthalmic device forming polymers and one or more silicone-urethane copolymers.

11 . The method of claim 1 , wherein the one or more ophthalmic device forming polymers comprise one of a polymer film, a melt pellet and a hot melt.

12 . The method of claim 1 , comprising:

(a) introducing the one or more ophthalmic device forming polymers into an anterior mold section;

(b) capping the anterior mold section with a posterior mold section mold; and

(c) direct compression molding the one or more ophthalmic device forming polymers to form an ophthalmic device.

13 . The method of claim 12 , wherein the one or more ophthalmic device forming polymers comprise one of a polymer film, a melt pellet and a hot melt.

14 . The method of claim 13 , wherein the one of a polymer film, a melt pellet and a hot melt comprises one or more of an aliphatic hydrophilic thermoplastic polyurethane, an aromatic hydrophilic thermoplastic polyurethane, an aliphatic hydrophilic thermoplastic polyester, an aromatic hydrophilic thermoplastic polyester, and a blend of one or more of the aliphatic hydrophilic thermoplastic polyurethane, the aromatic hydrophilic thermoplastic polyurethane, the aliphatic hydrophilic thermoplastic polyester, the aromatic hydrophilic thermoplastic polyester with a hydrophobic silicone.

15 . The method of claim 14 , wherein the aliphatic hydrophilic thermoplastic polyurethane comprises a reaction product of an aliphatic organic diisocyanate, a polyether polyol and a chain extender.

16 . The method of claim 13 , wherein the one of a polymer film, a melt pellet and a hot melt comprises a blend of one or more ophthalmic device forming polymers and one or more silicone polymers.

17 . The method of claim 16 , wherein the one or more silicone polymers include polydimethylsiloxane, dimethicone or both.

18 . The method of claim 13 , wherein the one of a polymer film, a melt pellet and a hot melt comprise a blend of the one or more ophthalmic device forming polymers and one or more silicone-urethane copolymers.

19 . The method of claim 1 , wherein the ophthalmic device is a contact lens.

20 . The method of claim 19 , further comprising hydrating the contact lens to form a soft contact lens.

Assignments (15)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (061391/0172) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072486/0769 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY INTEREST Recorded Feb 12, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066552/0041 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 055756/0298) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061873/0616 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 57287/0160) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061874/0539 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: TECHNOLAS PERFECT VISION GMBH; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061884/0514 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 055756/0281) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061777/0749 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 057287/0140) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061776/0836 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Sep 8, 2022
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 061391/0172 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
SECURITY INTEREST Recorded Aug 25, 2021
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH+LOMB IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057287/0160 →
SECURITY INTEREST Recorded Aug 25, 2021
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH+LOMB IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 057287/0140 →
SECURITY INTEREST Recorded Mar 29, 2021
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 055756/0281 →
SECURITY INTEREST Recorded Mar 29, 2021
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 055756/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2021
From: RAO, ARVIND M.; GRANEY, ANITA M.; JONES, THOMAS; DIBELLA, JAMES
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 055421/0936 →